Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent

ClinicalTrials.gov ID: NCT04936308

Public ClinicalTrials.gov record NCT04936308. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 7:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Who Had an Inadequate Response and/or Intolerance to One Prior Anti-Tumor Necrosis Factor Alpha Agent

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) and inadequate response (IR) and/or intolerance to a prior anti-tumor necrosis factor (TNF) by assessing the reduction in signs and symptoms of PsA.

Study identification

NCT ID
NCT04936308
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
453 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 28, 2021 (Actual)
Primary completion
Oct 28, 2024 (Actual)
Completion
Jul 2, 2026 (Actual)
Last update posted
Aug 20, 2026

2021 – 2026

United States locations

U.S. sites
50
U.S. states
22
U.S. cities
49
Facility City State ZIP Site status
Arthritis Associates Mountain Brook Alabama 35223 —
Arizona Arthritis and Rheumatology Research PLLC 2 Avondale Arizona 85392 —
Arizona Arthritis and Rheumatology Research PLLC 3 Flagstaff Arizona 86001-6218 —
Arizona Arthritis and Rheumatology Research PLLC Mesa Arizona 85210 —
Arizona Arthritis and Rheumatology Research PLLC 1 Phoenix Arizona 85032 —
Arizona Arthritis and Rheumatology Associates Sun City Arizona 85351 —
Southern Arizona VA Healthcare System Tucson Arizona 85723 —
Unity Health-White County Medical Center Searcy Arkansas 72143 —
Newport Huntington Medical Group Huntington Beach California 92648 —
Medvin Clinical Research 2 Thousand Oaks California 91360 —
Medvin Clinical Research Tujunga California 91042 —
Clinical Research Center of Connecticut Danbury Connecticut 06810 —
Bay Pines VA Healthcare System Bay Pines Florida 33744 —
Clinical Research of West Florida Clearwater Florida 33765 —
Omega Research Consultants DeBary Florida 32713 —
Advanced Clinical Research of Orlando Ocoee Florida 34761 —
Integral Rheumatology And Immunology Specialists Plantation Florida 33324 —
Clinical Research of West Florida 1 Tampa Florida 33606 —
Florida Medical Clinic, P.A. Zephyrhills Florida 33542 —
Great Lakes Clinical Trials Chicago Illinois 60640 —
Clinic of Robert Hozman Skokie Illinois 60076 —
The Arthritis and Diabetes Clinic Monroe Louisiana 71203 —
Johns Hopkins University Baltimore Maryland 21224 —
Klein And Associates M D P A Hagerstown Maryland 21740 —
Great Lakes Center of Rheumatology Lansing Michigan 48911 —
Arthritis and Rheumatology Center of MI Okemos Michigan 48864 —
Clinical Research Institute of Michigan, LLC Saint Clair Shores Michigan 48081 —
St. Paul Rheumatology P A Eagan Minnesota 55121 —
Arthritis Consultants St Louis Missouri 63141 —
Arthritis Rheumatic And Back Disease Associates Voorhees Township New Jersey 08043 —
Albuquerque Center for Rheumatology Albuquerque New Mexico 87102 —
Arthritis and Osteoperosis Associates of New Mexico Las Cruces New Mexico 88011 —
Buffalo Rheumatology and Medicine PLLC Orchard Park New York 14127 —
DJL Clinical Research, PLLC Charlotte North Carolina 28211 —
STAT Research, Inc. Vandalia Ohio 45377 —
Health Research of Oklahoma Oklahoma City Oklahoma 73103 —
Rheumatology Associates of Oklahoma Oklahoma City Oklahoma 73116 —
Dr. Ramesh Gupta Memphis Tennessee 38119 —
Precision Comprehensive Clinical Research Solutions Colleyville Texas 76034 —
Adriana Pop Moody MD Clinic PA Corpus Christi Texas 78404 —
Metroplex Clinical Research Center Dallas Texas 75231 —
Precision Comprehensive Clinical Research Solutions 1 Fort Worth Texas 76107 —
West Texas Clinical Research Lubbock Texas 79424 —
Southwest Rheumatology Research LLC Mesquite Texas 75150 —
Texas Rheumatology Care Plano Texas 75024 —
Advanced Rheumatology of Houston The Woodlands Texas 77382 —
DM Clinical Research Tomball Texas 77375 —
Arthritis And Osteoporosis Clinic Waco Texas 76710 —
Arthritis Northwest PLLC 1 Spokane Washington 99204 —
Rheumatology and Pulmonary Clinic Beckley West Virginia 25801 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 119 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04936308, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 20, 2026 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04936308 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →